PulteGroup Overview
Valuation check: PHM's ROE is 146.5%, above the Healthcare sector average of 29.39%.
Get informed when a big investor buys or sells
+ Follow14649.50%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for PHM is 146.5%. That is above the Healthcare sector average of 29.39%. Investors often review this figure alongside PulteGroup's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, PHM currently prints 146.5% for ROE, while the sector average sits near 29.39%. That is roughly 49745.0% above the sector mean. Large gaps often invite a closer look at PulteGroup's growth, margins, and balance sheet.
Return on Equity shows how effectively PulteGroup converts resources into returns. At 146.5%, PHM may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PHM's ROE (146.5%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack PulteGroup's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
